Order Article Reprints

Al-Sanea MM, Obaidullah AJ, Shaker ME, Chilingaryan G, Alanazi MM, Alsaif NA, Alkahtani HM, Alsubaie SA, Abdelgawad MA. A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights. Molecules. 2021; 26(2):412. https://doi.org/10.3390/molecules26020412

Al-Sanea, Mohammad M., Ahmad J. Obaidullah, Mohamed E. Shaker, Garri Chilingaryan, Mohammed M. Alanazi, Nawaf A. Alsaif, Hamad M. Alkahtani, Sultan A. Alsubaie, and Mohamed A. Abdelgawad. 2021. "A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights" Molecules 26, no. 2: 412. https://doi.org/10.3390/molecules26020412

Al-Sanea, M. M., Obaidullah, A. J., Shaker, M. E., Chilingaryan, G., Alanazi, M. M., Alsaif, N. A., Alkahtani, H. M., Alsubaie, S. A., & Abdelgawad, M. A. (2021). A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights. Molecules, 26(2), 412. https://doi.org/10.3390/molecules26020412